One year follow up for case series of myocarditis following mRNA vaccination against SARS-CoV-2

In 2021, the first rounds of modified mRNA vaccines against SARS-CoV-2 were tested and deployed. The vaccines themselves had great efficacy against severe infection, with rare and minimal side effects. One adverse effect that was reported, however, was incidence of myocarditis seen amongst mostly yo...

Descripción completa

Detalles Bibliográficos
Autores principales: Petersen, Matthew R., Budweg, Jeffery B., Matar, Ralph M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2023
Materias:
Research Letter
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10043964/
https://www.ncbi.nlm.nih.gov/pubmed/37006461
http://dx.doi.org/10.1016/j.ahjo.2023.100294
_version_ 1784913257992028160
author Petersen, Matthew R.
Budweg, Jeffery B.
Matar, Ralph M.
author_facet Petersen, Matthew R.
Budweg, Jeffery B.
Matar, Ralph M.
author_sort Petersen, Matthew R.
collection PubMed
description In 2021, the first rounds of modified mRNA vaccines against SARS-CoV-2 were tested and deployed. The vaccines themselves had great efficacy against severe infection, with rare and minimal side effects. One adverse effect that was reported, however, was incidence of myocarditis seen amongst mostly young males after their second vaccination dose. The disease course was self-limited. This study group published a case series in August of 2021 of four cases of this phenomenon. This paper is a followup to the original case series, providing an updated literature review and expert recommendations concerning the safety and benefits of the vaccines.
format Online
Article
Text
id pubmed-10043964
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-100439642023-03-28 One year follow up for case series of myocarditis following mRNA vaccination against SARS-CoV-2 Petersen, Matthew R. Budweg, Jeffery B. Matar, Ralph M. Am Heart J Plus Research Letter In 2021, the first rounds of modified mRNA vaccines against SARS-CoV-2 were tested and deployed. The vaccines themselves had great efficacy against severe infection, with rare and minimal side effects. One adverse effect that was reported, however, was incidence of myocarditis seen amongst mostly young males after their second vaccination dose. The disease course was self-limited. This study group published a case series in August of 2021 of four cases of this phenomenon. This paper is a followup to the original case series, providing an updated literature review and expert recommendations concerning the safety and benefits of the vaccines. Elsevier 2023-04 2023-03-28 /pmc/articles/PMC10043964/ /pubmed/37006461 http://dx.doi.org/10.1016/j.ahjo.2023.100294 Text en Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Research Letter
Petersen, Matthew R.
Budweg, Jeffery B.
Matar, Ralph M.
One year follow up for case series of myocarditis following mRNA vaccination against SARS-CoV-2
title One year follow up for case series of myocarditis following mRNA vaccination against SARS-CoV-2
title_full One year follow up for case series of myocarditis following mRNA vaccination against SARS-CoV-2
title_fullStr One year follow up for case series of myocarditis following mRNA vaccination against SARS-CoV-2
title_full_unstemmed One year follow up for case series of myocarditis following mRNA vaccination against SARS-CoV-2
title_short One year follow up for case series of myocarditis following mRNA vaccination against SARS-CoV-2
title_sort one year follow up for case series of myocarditis following mrna vaccination against sars-cov-2
topic Research Letter
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10043964/
https://www.ncbi.nlm.nih.gov/pubmed/37006461
http://dx.doi.org/10.1016/j.ahjo.2023.100294
work_keys_str_mv AT petersenmatthewr oneyearfollowupforcaseseriesofmyocarditisfollowingmrnavaccinationagainstsarscov2
AT budwegjefferyb oneyearfollowupforcaseseriesofmyocarditisfollowingmrnavaccinationagainstsarscov2
AT matarralphm oneyearfollowupforcaseseriesofmyocarditisfollowingmrnavaccinationagainstsarscov2

Ejemplares similares